Apellis Pharmaceuticals Inc (APLS)
41.30
-0.70
(-1.67%)
USD |
NASDAQ |
May 17, 16:00
41.30
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Gross Profit (Quarterly): 152.12M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 152.12M |
December 31, 2023 | 126.46M |
September 30, 2023 | 87.99M |
June 30, 2023 | 86.59M |
March 31, 2023 | 37.04M |
December 31, 2022 | 19.74M |
Date | Value |
---|---|
September 30, 2022 | 20.68M |
June 30, 2022 | 16.24M |
March 31, 2022 | 13.13M |
December 31, 2021 | 55.24M |
September 30, 2021 | 5.501M |
June 30, 2021 | 0.623M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.623M
Minimum
Jun 2021
152.12M
Maximum
Mar 2024
51.78M
Average
28.86M
Median
Gross Profit (Quarterly) Benchmarks
Blueprint Medicines Corp | 92.92M |
Sarepta Therapeutics Inc | 362.90M |
Inspire Medical Systems Inc | 139.25M |
Alnylam Pharmaceuticals Inc | 428.36M |
Biomarin Pharmaceutical Inc | 523.65M |